Please wait a minute...
Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology)  2010, Vol. 11 Issue (12): 895-904    DOI: 10.1631/jzus.B1000302
Biomedicine     
Improved myocardial perfusion and cardiac function by controlled-release basic fibroblast growth factor using fibrin glue in a canine infarct model
Shao-ping Nie, Xiao Wang, Shi-bin Qiao, Qiu-tang Zeng, Ju-quan Jiang, Xiao-qing Liu, Xiang-ming Zhu, Guo-xiang Cao, Chang-sheng Ma
Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China, Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
Download:     PDF (0 KB)     
Export: BibTeX | EndNote (RIS)      

Abstract  Objective: Angiogenic therapy is emerging as a potential strategy for the treatment of ischemic heart disease but is limited by a relatively short half-life of growth factors. Fibrin glue (FG) provides a reservoir for controlled-release of growth factors. The aim of this study was to evaluate the effects of basic fibroblast growth factor (bFGF) incorporating FG on angiogenesis and cardiac performance in a canine infarct model. Methods: Acute myocardial infarction was induced by ligation of the left anterior descending coronary artery (LAD). Group I (n=6) underwent ligation of LAD alone. In Group II, transmural channels were created in the infarct area (n=6). In Group III, non-transmural channels were created to locate FG cylinders containing bFGF (n=6). Eight weeks after operation, myocardial perfusion was assessed by single photon emission computed tomography, cardiac function by echocardiography, and vascular development by immunohistochemical staining. Results: Total vascular density and the number of large vessels (internal diameter ≥50 μm) were dramatically higher in Group III than in Groups I and II at eight weeks. Only the controlled-release group exhibited an improvement in regional myocardial perfusion associated with lower defect score. Animals in Group III presented improved cardiac regional systolic and diastolic functions as well as global systolic function in comparison with the other two groups. Conclusions: Enhanced and sustained angiogenic response can be achieved by controlled-release bFGF incorporating FG within transmyocardial laser channels, thus enabling improvement in myocardial perfusion and cardiac function.

Key wordsAngiogenesis      Basic fibroblast growth factor      Controlled release      Ischemic heart disease     
Received: 16 August 2010      Published: 09 December 2010
CLC:  R54  
Cite this article:

Shao-ping Nie, Xiao Wang, Shi-bin Qiao, Qiu-tang Zeng, Ju-quan Jiang, Xiao-qing Liu, Xiang-ming Zhu, Guo-xiang Cao, Chang-sheng Ma. Improved myocardial perfusion and cardiac function by controlled-release basic fibroblast growth factor using fibrin glue in a canine infarct model. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2010, 11(12): 895-904.

URL:

http://www.zjujournals.com/xueshu/zjus-b/10.1631/jzus.B1000302     OR     http://www.zjujournals.com/xueshu/zjus-b/Y2010/V11/I12/895

[1] Rados?aw Wieczór, Anna Maria Wieczór, Gra?yna Gadomska, Katarzyna Stankowska, Jacek Fabisiak, Karol Suppan, Grzegorz Pulkowski, Jacek Budzyński, Danuta Ro??. Overweight and obesity versus concentrations of VEGF-A, sVEGFR-1, and sVEGFR-2 in plasma of patients with lower limb chronic ischemia[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2016, 17(11): 842-849.
[2] Barbara Ruszkowska-Ciastek, Alina Sokup, Tomasz Wernik, Piotr Rhone, Krzysztof Góralczyk, Kornel Bielawski, Agata Fija?kowska, Aleksandra Nowakowska, El?bieta Rhone, Danuta Ro??. Low-grade risk of hypercoagulable state in patients suffering from diabetes mellitus type 2[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2015, 16(9): 788-795.
[3] Rados?aw Wieczór, Gra?yna Gadomska, Barbara Ruszkowska-Ciastek, Katarzyna Stankowska, Jacek Budzyński, Jacek Fabisiak, Karol Suppan, Grzegorz Pulkowski, Danuta Ro??. Impact of type 2 diabetes on the plasma levels of vascular endothelial growth factor and its soluble receptors type 1 and type 2 in patients with peripheral arterial disease[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2015, 16(11): 948-956.
[4] Barbara Ruszkowska-Ciastek, Alina Sokup, Maciej W. Socha, Zofia Ruprecht, Lidia Ha?as, Barbara Góralczyk, Krzysztof Góralczyk, Gra?yna Gadomska, Danuta Ro??. A preliminary evaluation of VEGF-A, VEGFR1 and VEGFR2 in patients with well-controlled type 2 diabetes mellitus[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2014, 15(6): 575-581.
[5] Jian Shen, Yu Zhu, Hai Yu, Zuo-xu Fan, Feng Xiao, Pan Wu, Qi-hui Zhang, Xiao-xing Xiong, Jian-wei Pan, Ren-ya Zhan. Buyang Huanwu decoction increases angiopoietin-1 expression and promotes angiogenesis and functional outcome after focal cerebral ischemia[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2014, 15(3): 272-280.
[6] Xin-yang Hu, Wen-xia Wang, Min-jia Yu, Xian-bao Liu, Rong-rong Wu, Feng Gao, Xin Huang, Jiang Cao, Xiao-jie Xie, Jian-an Wang. Tongxinluo promotes mesenchymal stem cell tube formation in vitro[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2011, 12(8): 644-651.
[7] Qin Zhao, Zhi-dong Liu, Yong Xue, Jing-feng Wang, Hui Li, Qing-juan Tang, Yu-ming Wang, Ping Dong, Chang-hu Xue. Ds-echinoside A, a new triterpene glycoside derived from sea cucumber, exhibits antimetastatic activity via the inhibition of NF-κB-dependent MMP-9 and VEGF expressions[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2011, 12(7): 534-544.
[8] CUI Hong-guang, LI Hui-yan. Effect of basic fibroblast growth factor (bFGF) on the treatment of exposure of the orbital implants[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2007, 8(9): 620-625.
[9] ZHANG Ying, YE Li-ping, WANG Biao, CAO Shi-cheng, SUN Li-guang. Effect of lead on ERK activity and the protective function of bFGF in rat primary culture astroglia[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2007, 8(6): 422-427.
[10] GRIZZI Fabio, FRANCESCHINI Barbara, FIAMENGO Barbara, RUSSO Carlo, DIOGUARDI Nicola. Vascular architecture: is it a helpful histopathological biomarker for hepatocellular carcinoma?[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2007, 8(4): 217-220.
[11] ZHANG Mao, MA Yue-feng, GAN Jian-xin, JIANG Guan-yu, XU Shan-xiang, TAO Xiang-luo, HONG An, LI Jiao-kun. Basic fibroblast growth factor alleviates brain injury following global ischemia reperfusion in rabbits[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2005, 6( 7): 6-.